Can DSM Firmenich merger deliver on its synergistic promise?

 

A slide from DSM Firmenich’s presentation next week…

 

DSM and Firmenich’s mooted 2023 ‘Merger of Equals’ will
create a nutrition, food ingredients and fragrances
behemoth with 277 years of collective business
experience and a combined annual revenue pushing
towards €12 billion (£10.2bn).

The deal rivals that of the 2021 €20bn+ (£17bn+) merger between International Flavors & Fragrances (IFF)
and DuPont’s Nutrition and Biosciences division.

The Dutch and Swiss firms have spoken much of the synergies they predict will save at least €175 million
(£149m), while not cutting too many of 28,000 jobs and keeping annual R&D spends higher than most
rivals at 9.3% of revenue – about €700m (£145m).

By comparison, Givaudan spends 8.4% of its revenues on R&D, IFF/DuPont 6.1% and Symrise 5.9%.
More here.

Saturated Fat: Nutritionists Press Authorities to Reconsider

As the nutrition science consensus shifts in favor of saturated fat after decades in the dietary sin bin over odious health links, dairy players say it’s time for full-fat segregation to end – especially as dairy under-consumption remains prevalent across the globe.

Armed with what they consider compelling dairy consumption statistics plus an ever-growing body of peer-reviewed research showing saturated fat is probably not – at least singularly – the agent of ailments like high cholesterol, heart disease and obesity it has been tagged with down the decades, the push to have full-fat dairy reinstated in national dietary guidelines is well and truly on.

‘Satfat’-friendly data is being presented to the committees that inform such guidelines while multi-channel dairy education campaigns aimed at consumers, regulators and the broader food industry are amplifying the full-fat dairy message and its potential to elevate across-the-board dairy consumption.

More here.